Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer

NCT00138151 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

33

Enrollment

OTHER

Sponsor class

Stopped Slow accrual and lack of study drug

Conditions

Cervical Cancer

Interventions

BIOLOGICAL: recombinant interferon alpha-2b
DRUG: isotretinoin
DRUG: paclitaxel

Sponsor

University of Medicine and Dentistry of New Jersey

Collaborators

[object Object]